In search of the optimal setting for statin trials in prostate cancer: the power of population-based studies

Prostate Cancer Prostatic Dis. 2021 Sep;24(3):583-584. doi: 10.1038/s41391-021-00355-y. Epub 2021 Mar 29.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / standards*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Prognosis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / epidemiology
  • Prostatic Neoplasms / pathology
  • Randomized Controlled Trials as Topic / statistics & numerical data*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors